Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals
Clinical Benefit
| Substantial |
Le service médical rendu par COSOPT 20 mg/5 ml/ml, collyre en solution en récipient unidose, est important.
|
Clinical Added Value
| no clinical added value |
COSOPT 20 mg/5 mg/ml, collyre en solution en récipient unidose, n'apporte pas d'amélioration du service médical rendu (niveau V) par rapport COSOPT, collyre en solution en flacon multidose.
|
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
tdPSMD4Pn01EEW0p
